JHJennifer A. Harvey

Jennifer A. Harvey

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jennifer A. Harvey has a total of 138 co-authors. Here are the top co-authors by number of shared publications:

  • Brandi T. Nicholson

    Department of Radiology, University of Virginia, Charlottesville, Virginia 22908, USA

    5 shared publications
  • Kathy Repich

    Department of Radiology and Medical Imaging, University of Virginia Health System , Charlottesville, VA , USA

    4 shared publications
  • Carrie M Rochman

    Department of Radiology and Medical Imaging, University of Virginia Health System , Charlottesville, VA , USA

    3 shared publications
  • David E. March

    Director of Breast Imaging, Radiology & Imaging Inc. and Baystate Medical Center, Springfield, Massachusetts, Assistant Professor of Radiology, Tufts University School of Medicine, Boston, Massachusetts

    3 shared publications
  • James Gordon Mainprize

    Sunnybrook Research Institute

    3 shared publications
  • James T Patrie

    Department of Public Health Sciences, University of Virginia School of Medicine , Charlottesville, VA

    3 shared publications

Latest Publications

  • Open Access

    Cryoablation and Intratumoral Immunotherapy for Breast Cancer: A Future Path to Cost-Effective De-Escalation for Larger Tumors, Lymph Nodes and Metastatic Disease

    by Josephine Fermanian, Robert C. Ward, Dennis R. Holmes, Ariel C. Fisher, Jennifer Harvey, Brian Marples, Peter J. Littrup

    Cryoablation is a promising, cost-effective option to de-escalate surgical breast cancer morbidity, but presently is only suggested for breast cancers < 1.5 cm, in select candidates. Breast cancer cryoablation is not a reliably covered procedure by insurance and is mainly guided by ultrasound (US), using a single cryoprobe. Yet, cryoablation is an accepted treatment option for various malignancies, including those of the kidney, liver and lung, utilizing a predominantly CT-guided, multi-probe approach using crucial cytotoxic isotherms for thorough tumor coverage. Cryoablation thus continues to find new clinical utility and is rapidly advancing on multiple fronts, similar to immunotherapy. Clinical concerns of expanding cryoablation to breast tumors > 1.5 cm is more related to the greater risk of metastatic spread to local lymph nodes and beyond. Combined adjuvant treatment, such as radiation and/or chemotherapy, are currently used for regional and systemic breast cancer control, but have significant associated morbidities. US/CT-guided multi-probe large-volume breast cryoablation is presented as a thorough local control option for select patients. Intratumoral chemotherapy by direct tumor injection has been shown to be safe and is currently being tested with immunotherapy drugs and exhibits much lower morbidity. Cryoablation combined with intratumoral immunotherapy is presented to show robust systemic immune response and the potential to provide additional protection from regional and/or metastatic disease spread while de-escalating the morbidities from current adjuvant treatments for larger breast cancers. While further clinical trials are needed, it is essential to pursue safe and effective breast cancer treatments that offer the potential for cost-efficiency and therapeutic de-escalation across a wide spectrum of breast cancer cases.


  • Patient Experience of Women With Dense Breasts Undergoing Screening Contrast-Enhanced Mammography

    by Matthew M Miller, Shanna Mayorov, Ramapriya Ganti, Jonathan V Nguyen, Carrie M Rochman, Matthew Caley, Jessie Jahjah, Kathy Repich, James T Patrie, Roger T Anderson, et al.

    We investigated patient experience with screening contrast-enhanced mammography (CEM) to determine whether a general population of women with dense breasts would accept CEM in a screening setting. In this institutional review board–approved prospective study, patients with heterogeneous and extremely dense breasts on their mammogram were invited to undergo screening CEM and complete pre-CEM and post-CEM surveys. On the pre-CEM survey, patients were asked about their attitudes regarding supplemental screening in general. On the post-CEM survey, patients were asked about their experience undergoing screening CEM, including causes and severity of any discomfort and whether they would consider undergoing screening CEM again in the future or recommend it to a friend. One hundred sixty-three women were surveyed before and after screening CEM. Most patients, 97.5% (159/163), reported minimal or no unpleasantness associated with undergoing screening CEM. In addition, 91.4% (149/163) said they would probably or very likely undergo screening CEM in the future if it cost the same as a traditional screening mammogram, and 95.1% (155/163) said they would probably or very likely recommend screening CEM to a friend. Patients in this study, who were all willing to undergo CEM, more frequently reported a family history of breast cancer than a comparison cohort of women with dense breasts (58.2% vs 47.1%, P = .027). Patients from a general population of women with dense breasts reported a positive experience undergoing screening CEM, suggesting screening CEM might be well received by this patient population, particularly if the cost was comparable with traditional screening mammography.


  • Open Access

    Multi-Pronged Solutions Addressing Barriers to Breast Screening Access in Appalachia

    by Cara Brooks Safon, George Batten, Gloribel Bonilla, Brenna Robinson, Fabian Camacho, Jennifer Harvey, Roger Anderson, Marianne Messersmith Hillemeier, Christopher Louis

    Annual mammography screening is recommended by the US Preventive Services Task Force (USPSTF) and American Cancer Society (ACS) to reduce mortality through early detection of breast cancer. In rural Appalachia, rates of later-stage breast cancer incidence and mortality are higher than national averages. We explored the ways that providers and staff at breast cancer screening facilities employed novel approaches to overcome patient- and facility-level barriers to access to breast cancer screening in the Appalachian region. We conducted 23 semi-structured interviews with 28 clinical providers and staff of breast health facilities in Appalachia. Themes reflect how limiting features of breast screening facilities influenced access to care; the way patient-level barriers presented challenges to access to breast screening; and that external and regulatory forces presented obstacles to access to care. In addition, the unique geographical and geographical attributes of the Appalachian region shaped access and adherence to mammography screening recommendations. Thematic findings highlight that facilities implemented patient-centered strategies to overcome access-related barriers. Results may inform the ways breast cancer screening facilities address suboptimal access to breast health screening. They may also inform future resource allocations to enable facilities to reach breast cancer screening performance goals.


  • Open Access

    The Future Is in the Details, and a Farewell

    by Jennifer A Harvey

    I am typically more worried about a solid round mass than an oval circumscribed mass seen in any modality. While BI-RADS ( 1) assessment category 3 has relatively well-defined indications for mammography and US, the indications are less clear for MRI. In fact, the BI-RADS Atlas states, “The use of category 3 assessment at MRI remains intuitive for radiologists who lack extensive (audited) personal experience with any specific type of lesion” ( 1).

  • Open Access

    Using a “Wide Lens”

    by Jennifer A Harvey

    The landscape of imaging meeting exhibit halls has changed considerably over the years. I recall being completely overwhelmed at attending my first few big meetings. While equipment vendors continue to have expansive booths to showcase their products, more and more real estate is now being occupied by small and mid-size vendors of artificial intelligence (AI) programs. These can range from improving workflow efficiency to detection of important findings, which seems very positive.

  • Factors Associated With Breast Cancer Screening Behaviors Among Women With Dense Breasts

    by Matthew M Miller, Ramapriya Ganti, Kathy Repich, James T Patrie, Roger T Anderson, Jennifer A Harvey

    We sought to identify patient factors associated with patient-reported screening behaviors in women with dense breasts. An IRB-approved survey study of women with dense breasts presenting for annual screening mammography at an outpatient imaging center was previously conducted from March 2017 to February 2018. The survey included questions regarding mammographic screening frequency and recent participation in supplemental screening. These survey data were combined post hoc with clinical and demographic data and socioeconomic data imputed from census data. Logistic regression was used to identify patient factors associated with reported screening behaviors. Surveys were completed by 508 women (median age, 59.0 years; range, 31.0–86.0 years) with dense breasts. Multivariable analysis demonstrated an independent association of undergoing mammographic screening annually with a history of discussing breast density with a doctor (adjusted odds ratio [AOR], 2.60; P = 0.019). Undergoing supplemental screening in the previous three years was independently associated with younger age (AOR, 1.59; P = 0.004), strong family history of breast cancer (AOR, 3.84; P = 0.027), higher perceived personal risk for breast cancer (AOR, 3.47; P = 0.004), and increased concern about radiation associated with screening examinations (AOR, 3.31; P = 0.006). Women with dense breasts who had discussed breast density with a doctor were more likely to report undergoing annual screening mammography, while younger women and women with a strong family history of breast cancer, higher perceived personal risk for breast cancer, or greater concern about radiation were more likely to report recently undergoing supplemental screening.


  • Broadening Our Perspective of Health Care Inequities

    by Jennifer A Harvey

    Our Science of Screening article on disparities in breast cancer screening and treatment brings to light an underserved population that many may not be aware of—American Indians and Alaska Natives (AI/AN). These women have a much lower incidence of breast cancer (95 cases/100 000) compared with Black (127/100 000) and White (131/100 000) women ( 1), but with an increasing incidence approaching that of White women ( 2). Breast cancer is the leading site of cancer in AI/AN women, although lung cancer leads to the most cancer deaths. However, these women are less likely to be diagnosed at an early stage, and breast cancer mortality has not significantly declined as it has for both Black and White women over the last four decades. I find this shocking. This excellent article by Kurumety et al ( 1) provides tremendous insight into why this is so, but also proposes some meaningful interventions ( 1). Similar to other underserved populations, access and geography are high on the list of barriers, as are cultural differences. I admit to thinking of areas of health disparities as inner cities and rural areas. I feel that I should have known better; I was born in Alaska and grew up in Arizona—two of the states that have the most square miles of AI/AN land—and I was intimately aware of the AI/AN communities. When we lived in Alaska, Linda, a young Alaskan native, lived with our family for many years after her mother had passed, and other relatives were not able to care for her at the time. She eventually returned to Alaska and became a nurse. We are still in regular contact and consider her a part of our family. Growing up in the Phoenix area, our house was about a half-mile from the Akimel O’odham (“River People,” formerly known as Pima) reservation (the Salt River Pima—Maricopa Indian Community) where the best cotton in the world is grown (Pima cotton). Although geographically close, there was regretfully little interaction between communities. I attended Northern Arizona University in Flagstaff, which is adjacent to the Navajo Nation, a 27 000 square mile reservation in northeast Arizona that is larger than 10 U.S. states. Yáʼátʼééh (Navajo, meaning hello or goodbye) was commonly said and heard in Flagstaff. One of my good friends, Ronnie, was from the Navajo Nation, and we shared stories of our youth. I spent many of my younger days traveling through tribal lands in awe of their beauty but also struck by the lack of infrastructure, including electricity and water supply. However, even as a physician—and even given my geographic and personal proximity to AI/AN lands and people—it had not occurred to me that there would be such breast cancer disparities for AI/AN peoples. The article in this month’s issue of JBI broadened my perspective far beyond the handful of people that I have known. While I have great respect, my knowledge and experience are clearly very superficial. I pledge to actively reach out to the tribal nations in upstate New York, my home now, and hope others will do the same.

  • Breast Radiologists as Clinicians

    by Jennifer A Harvey

    Early in my career, I had a conversation with another radiologist about a patient with a palpable breast lump. I had performed a limited clinical exam before that was commonplace for breast radiologists and described the findings in my report, which correlated well with the imaging findings. Interestingly, my colleague was aghast that I had performed a breast exam because that was not under our purview, and all clinical findings should be managed by “clinicians.” My thought was “I am a doctor—I went to medical school and performed many clinical exams.” We as breast radiologists see many more breast cancers in a year than most primary care providers will see in an entire career—and we have immediate correlation with the imaging findings. My mindset on this was burned into my psyche in residency, where I trained under Dr Michael Pitt, a well-known musculoskeletal radiologist. If you ever said the term “clinicians,” he would stop you immediately and say, “You need to call them ‘the other clinicians.’ We radiologists are also clinicians.” I am a radiologist, and I am a clinician.


  • Practical Steps to Writing a Scientific Manuscript

    by Lars J Grimm, Jennifer A Harvey

    Writing a scientific manuscript can be a very intimidating process for new writers. However, writing a scientific research article can be broken down into discrete steps to make the process more digestible. Radiology manuscripts have common conventions that differ from research in technical and other medical fields. The practical steps summarized within describe what to do before you start writing, successful writing strategies, and common writing styles. Templates for producing an abstract, introduction, methods, results, and discussion are outlined, along with tips to collect references and produce high quality figures. All writers can benefit from an outside writing perspective, and the practical steps described should ease the transition from a blank page to a finished manuscript.